LucyDx

LucyDx

Early Stage

Early detection of diabetic retinopathy

Early detection of diabetic retinopathy

Overview

Raised to Date: Raised: $12,192

Total Commitments ($USD)

Platform

Netcapital

Start Date

03/29/2023

Close Date

07/31/2024

Min. Goal
$10,000
Max. Goal
$608,000
Min. Investment

$104

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$8.00

Pre-Money Valuation

$8,000,000

Rolling Commitments ($USD)

Status

Active

Reporting Date

04/24/2024

Days Remaining

97

% of Min. Goal

122%

% of Max. Goal

2%

Likelihood of Max
unlikely
Avg. Daily Raise

$31

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2021

Industry

Healthcare & Pharmaceuticals

Tech Sector

Medtech

Distribution Model

B2B2C

Margin

Medium

Capital Intensity

High

Location

NEWARK, Delaware

Business Type

Growth

LucyDx, with a valuation of $8 million, is raising funds on NetCapital. It is a medical technology company developing a diagnostic headset for the early detection of diabetic retinopathy. The non-invasive and compact headset of LucyDx is based on an electroretinogram and aims to prevent blindness through early detection. LucyDx has pinpointed its target market, validated demand, and is working with researchers at Emory University, Georgia Tech, and the VA Atlanta Medical Center. Andreas Inmann and Antoin Johnson founded LucyDx in February 2021. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1 million. The campaign proceeds will be used for product development, regulatory affairs, operations and payroll, prototyping, and testing.

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-15,878

$1,035

Summary Balance Sheet

FY 2023 FY 2022

Cash

$9,031

$14,362

Accounts Receivable

$0

$0

Total Assets

$9,031

$14,362

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 03/29/2023
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
LucyDx on NetCapital 2023
Platform: Netcapital
Security Type: Equity - Common
Valuation: $8,000,000
Price per Share: $8.00

Follow company

Follow LucyDx on NetCapital 2023

Buy LucyDx's Deal Report

LucyDx Deal Report

Get KingsCrowd’s comprehensive report on LucyDx including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether LucyDx is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the LucyDx deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge